Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
GURUGRAM, India and WILMINGTON, Del., Aug. 19, 2025 /PRNewswire/ -- The Chemours Company (Chemours)…
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
July 11, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. Complete Response…
